Search Results - I. O. Stoma
- Showing 1 - 13 results of 13
-
1
Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem by I. O. Stoma
Published 2023-04-01
Article -
2
Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma by I. O. Stoma
Published 2021-01-01
Article -
3
Possibilities and Prospects of Modification of the Intestinal Microbiome by E. G. Malaeva, I. O. Stoma
Published 2022-10-01
Article -
4
Microbiota and Long-Term Prognosis in Liver Cirrhosis by E. G. Malaeva, I. O. Stoma
Published 2024-06-01
Article -
5
Analyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutions by K. S. Korsak, E. V. Voropaev, I. O. Stoma
Published 2022-09-01
Article -
6
The COVID-19 crisis as a vector for changes in healthcare by K. S. Korsak, E. V. Voropaev, A. A. Kovalev, T. M. Sharshakova, I. O. Stoma
Published 2024-01-01
Article -
7
Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sin... by K. S. Korsak, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev
Published 2023-03-01
Article -
8
Urobiota and urinary tract infections in liver cirrhosis by E. G. Malaeva, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev
Published 2025-02-01
Article -
9
Sarcopenia in chronic liver disease, can we predict complications? by U. R. Salimov, I. O. Stoma, D. A. Fedoruk, A. A. Kovalev, A. E. Scherba, O. O. Rummo
Published 2022-12-01
Article -
10
The «microbiome» of post-liver transplant complications by U. R. Salimov, I. O. Stoma, A. E. Scherba, A. M. Fedoruk, A. A. Kovalev, O. O. Rummo
Published 2022-07-01
Article -
11
Efficacy of COVID-19 vaccination in organized group: results of a prospective study by I. O. Stoma, E. S. Korsak, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev, O. L. Tumash, D. D. Redko
Published 2023-01-01
Article -
12
Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28) by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, D. M. Los, O. V. Osipkina, A. Yu. Braga, A. A. Kovalev, A. V. Molchanova, N. V. Trofimova, O. S. Pershenkova, B. S. Yaroshevich, M. N. Mirge
Published 2024-07-01
Article -
13
Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, K. S. Korsak, O. V. Osipkina, A. V. Molchanova, A. A. Kovalev, D. M. Los, A. A. Ziatskov, A. S. Shaforost, M. N. Yatsuk, A. Yu. Braga, N. V. Trofimova, A. M. Dronina, E. L. Gasich, V. A. Gorbunov, A. Ev. Hancharou
Published 2025-01-01
Article